E
Eone Diagnomics Genome Center Co Ltd
KOSDAQ:245620
Eone Diagnomics Genome Center Co Ltd
KOSDAQ:245620
Price:
415
KRW
-5.25%
Market Closed
Market Cap:
₩57.5B
Balance Sheet
Balance Sheet Decomposition
Eone Diagnomics Genome Center Co Ltd
Eone Diagnomics Genome Center Co Ltd
Balance Sheet Decomposition is not available for
Eone Diagnomics Genome Center Co Ltd
Eone Diagnomics Genome Center Co Ltd
Balance Sheet
Eone Diagnomics Genome Center Co Ltd
Eone Diagnomics Genome Center Co Ltd
Currency: KRW
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
3 499
|
7 603
|
17 898
|
17 905
|
60 603
|
27 537
|
4 685
|
9 435
|
9 528
|
|
| Cash |
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
3 498
|
7 602
|
17 897
|
17 904
|
60 603
|
27 536
|
4 685
|
9 435
|
9 528
|
|
| Short-Term Investments |
999
|
312
|
1 578
|
120
|
380
|
60
|
300
|
300
|
38
|
|
| Total Receivables |
376
|
1 301
|
15 734
|
21 729
|
23 766
|
13 988
|
20 392
|
23 987
|
9 249
|
|
| Accounts Receivables |
375
|
1 260
|
15 402
|
20 012
|
21 357
|
11 751
|
20 253
|
23 360
|
8 988
|
|
| Other Receivables |
1
|
41
|
331
|
1 717
|
2 409
|
2 236
|
140
|
628
|
261
|
|
| Inventory |
273
|
505
|
5 014
|
3 922
|
3 502
|
8 353
|
10 256
|
10 381
|
8 105
|
|
| Other Current Assets |
131
|
391
|
1 484
|
2 345
|
7 157
|
9 293
|
5 978
|
2 149
|
17 930
|
|
| Total Current Assets |
5 279
|
10 112
|
41 707
|
46 021
|
95 408
|
59 230
|
41 612
|
46 252
|
44 850
|
|
| PP&E Net |
2 176
|
2 393
|
4 073
|
11 133
|
12 173
|
54 404
|
87 894
|
87 761
|
60 608
|
|
| PP&E Gross |
2 176
|
2 393
|
4 073
|
11 133
|
12 173
|
54 404
|
87 894
|
87 761
|
60 608
|
|
| Accumulated Depreciation |
508
|
849
|
1 658
|
3 375
|
5 556
|
12 198
|
15 920
|
20 177
|
16 631
|
|
| Intangible Assets |
87
|
595
|
4 452
|
5 400
|
5 930
|
11 438
|
9 954
|
7 837
|
7 158
|
|
| Goodwill |
0
|
0
|
12 652
|
11 241
|
11 241
|
23 031
|
23 091
|
14 139
|
11 735
|
|
| Note Receivable |
0
|
0
|
1 166
|
2 923
|
817
|
1 255
|
564
|
1 306
|
4
|
|
| Long-Term Investments |
864
|
451
|
10 750
|
19 012
|
34 043
|
35 605
|
28 286
|
15 413
|
10 507
|
|
| Other Long-Term Assets |
84
|
194
|
303
|
671
|
692
|
1 976
|
610
|
811
|
21
|
|
| Other Assets |
0
|
0
|
12 652
|
11 241
|
11 241
|
23 031
|
23 091
|
14 139
|
11 735
|
|
| Total Assets |
8 489
N/A
|
13 746
+62%
|
75 102
+446%
|
96 400
+28%
|
160 305
+66%
|
186 938
+17%
|
192 011
+3%
|
173 519
-10%
|
134 882
-22%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
388
|
1 115
|
17 392
|
16 099
|
17 479
|
16 293
|
15 226
|
9 650
|
5 493
|
|
| Accrued Liabilities |
75
|
93
|
204
|
622
|
635
|
837
|
486
|
667
|
21 162
|
|
| Short-Term Debt |
1 100
|
1 100
|
2 500
|
4 824
|
1 975
|
625
|
16 887
|
3 075
|
981
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
267
|
19 130
|
47 651
|
22 650
|
26 720
|
28 044
|
51 844
|
|
| Other Current Liabilities |
318
|
679
|
1 320
|
2 897
|
15 706
|
19 500
|
49 131
|
46 112
|
35 509
|
|
| Total Current Liabilities |
1 881
|
2 986
|
21 682
|
43 572
|
83 445
|
59 905
|
108 451
|
87 548
|
114 990
|
|
| Long-Term Debt |
5 322
|
0
|
333
|
3 337
|
4 958
|
59 781
|
40 105
|
39 919
|
7 957
|
|
| Deferred Income Tax |
0
|
0
|
1 583
|
1 320
|
1 594
|
8 061
|
7 923
|
6 940
|
7 534
|
|
| Minority Interest |
0
|
0
|
6 839
|
8 370
|
0
|
887
|
887
|
887
|
887
|
|
| Other Liabilities |
0
|
0
|
0
|
359
|
295
|
195
|
2 696
|
0
|
0
|
|
| Total Liabilities |
7 203
N/A
|
2 986
-59%
|
30 438
+919%
|
56 958
+87%
|
90 292
+59%
|
128 830
+43%
|
160 062
+24%
|
135 294
-15%
|
131 367
-3%
|
|
| Equity | ||||||||||
| Common Stock |
2 432
|
2 855
|
3 617
|
3 617
|
4 291
|
8 369
|
8 408
|
11 802
|
13 849
|
|
| Retained Earnings |
6 762
|
13 049
|
20 663
|
30 457
|
40 866
|
61 533
|
91 397
|
124 424
|
170 027
|
|
| Additional Paid In Capital |
5 616
|
20 956
|
67 413
|
70 707
|
93 126
|
97 968
|
98 748
|
144 416
|
151 179
|
|
| Unrealized Security Profit/Loss |
0
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
5 705
|
5 705
|
5 705
|
5 130
|
4 148
|
201
|
201
|
|
| Other Equity |
0
|
9
|
2
|
1 279
|
19 166
|
18 433
|
20 339
|
6 631
|
8 714
|
|
| Total Equity |
1 286
N/A
|
10 759
+737%
|
44 665
+315%
|
39 442
-12%
|
70 013
+78%
|
58 108
-17%
|
31 948
-45%
|
38 224
+20%
|
3 515
-91%
|
|
| Total Liabilities & Equity |
8 489
N/A
|
13 746
+62%
|
75 102
+446%
|
96 400
+28%
|
160 305
+66%
|
186 938
+17%
|
192 011
+3%
|
173 519
-10%
|
134 882
-22%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
59
|
70
|
88
|
88
|
99
|
100
|
102
|
119
|
138
|
|
Switch to:
Switch to:
See Also
Discover More
